Concepedia

Diane E. Normandin

DE

Statistics

Publications

30

Citations

1.5K

H-Index

21

Active since

1991

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Pfizer (United States)

Diane E. Normandin is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, molecular pharmacology, and medicine.

Publications per year

1991–2007

30

Publications

30

Cyclooxygenase-2???Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients

Andrew Whelton, John G. Fort, Joseph A. Puma et al. · American Journal of Therapeutics · 2001 · 335 citations

, , +17

Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946

Gary J. Grover, Steven Dzwonczyk, Diane M. McMullen et al. · Journal of Cardiovascular Pharmacology · 1995 · 258 citations

, , +14

Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate.

John R. McCullough, Diane E. Normandin, Mary Lee Conder et al. · Circulation Research · 1991 · 138 citations

, , +17

Cardioselective Antiischemic ATP-Sensitive Potassium Channel (K<sub>ATP</sub>) Openers. 5. Identification of 4-(<i>N</i>-Aryl)-Substituted Benzopyran Derivatives with High Selectivity

George C. Rovnyak, Syed Z. Ahmed, Charles Z. Ding et al. · Journal of Medicinal Chemistry · 1997 · 67 citations

, , +17

Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle.

Michael J. Antonaccio, Diane E. Normandin, R Serafino et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 55 citations

, , +10

1–5 of 30